Publikationen

Im Jahr 2018 wurden durch das KHFI 113 Originalarbeiten sowie 14 Reviews/Editorials in begutachteten Zeitschriften mit einem kumulierten Impact Factor von 839 publiziert.

Eine vollständige Liste aller Publikationen 2014-2018 findet man hier.

10 ausgewählte Publikationen aus 2018: 

  1. 1.
    Gaede L, Blumenstein J, Liebetrau C, Dörr O, Kim W, Nef H, et al. Outcome after transvascular transcatheter aortic valve implantation in 2016. Eur Heart J [Internet]. 2018;39:667–75. Available from: https://www.ncbi.nlm.nih.gov/pubmed/29228149
  2. 2.
    Hamm C, Mohr F, Heusch G. Lessons Learned From the German Aortic Valve Registry. J Am Coll Cardiol [Internet]. 2018;72:689–92. Available from: https://www.ncbi.nlm.nih.gov/pubmed/30072000
  3. 3.
    Keller T, Wanner C, Krane V, Kraus D, Genser B, Scharnagl H, et al. Prognostic Value of High-Sensitivity Versus Conventional Cardiac Troponin T Assays Among Patients With Type 2 Diabetes Mellitus Undergoing Maintenance Hemodialysis. Am J Kidney Dis [Internet]. 2018;71:822–30. Available from: https://www.ncbi.nlm.nih.gov/pubmed/29310884
  4. 4.
    Kim W, Gaede L, Husser O, Liebetrau C, Renker M, Rolf A, et al. Computed Tomography for Diagnosis and Classification of Bicuspid Aortic Valve Disease in Transcatheter Aortic Valve Replacement. JACC Cardiovasc Imaging [Internet]. 2018;11:1539–40. Available from: https://www.ncbi.nlm.nih.gov/pubmed/29454778
  5. 5.
    Kim W, Hengstenberg C, Hilker M, Kerber S, Schäfer U, Rudolph T, et al. The SAVI-TF Registry: 1-Year Outcomes of the European Post-Market Registry Using the ACURATE neo Transcatheter Heart Valve Under Real-World Conditions in 1,000 Patients. JACC Cardiovasc Interv [Internet]. 2018;11:1368–74. Available from: https://www.ncbi.nlm.nih.gov/pubmed/30025731
  6. 6.
    Kim W, Möllmann H, Liebetrau C, Renker M, Rolf A, Simon P, et al. The ACURATE neo Transcatheter Heart Valve: A Comprehensive Analysis of Predictors of Procedural Outcome. JACC Cardiovasc Interv [Internet]. 2018;11:1721–9. Available from: https://www.ncbi.nlm.nih.gov/pubmed/29803694
  7. 7.
    Kriechbaum S, Wiedenroth C, Wolter J, Hütz R, Haas M, Breithecker A, et al. N-terminal pro-B-type natriuretic peptide for monitoring after balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension. J Heart Lung Transplant [Internet]. 2018;37:639–46. Available from: https://www.ncbi.nlm.nih.gov/pubmed/29329761
  8. 8.
    Sperzel J, Defaye P, Delnoy P, Garcia G, Knops R, Tondo C, et al. Primary safety results from the LEADLESS Observational Study. Europace [Internet]. 2018;20:1491–7. Available from: https://www.ncbi.nlm.nih.gov/pubmed/29365073
  9. 9.
    Tjong F, Knops R, Neuzil P, Petru J, Sediva L, Wilde A, et al. Midterm Safety and Performance of a Leadless Cardiac Pacemaker: 3-Year Follow-up to the LEADLESS Trial (Nanostim Safety and Performance Trial for a Leadless Cardiac Pacemaker System). Circulation [Internet]. 2018;137:633–5. Available from: https://www.ncbi.nlm.nih.gov/pubmed/29431664
  10. 10.
    Vranckx P, Valgimigli M, Jüni P, Hamm C, Steg P, Heg D, et al. Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial. Lancet [Internet]. 2018;392:940–9. Available from: https://www.ncbi.nlm.nih.gov/pubmed/30166073

(1–10)